Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma

  • G K Abou-Alfa
  • , S Qin
  • , B-Y Ryoo
  • , S-N Lu
  • , C-J Yen
  • , Y-H Feng
  • , H Y Lim
  • , F Izzo
  • , M Colombo
  • , D Sarker
  • , L Bolondi
  • , G Vaccaro
  • , W P Harris
  • , Z Chen
  • , R A Hubner
  • , T Meyer
  • , W Sun
  • , J J Harding
  • , E M Hollywood
  • , J Ma
    • P J Wan, M Ly, J Bomalaski, A Johnston, C-C Lin, Y Chao, L-T Chen

Research output: Contribution to journal › Article › peer-review

178 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science